The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Asn Inc Regulatory News (AAIF)

Share Price Information for Abrdn Asn Inc (AAIF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 211.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.948%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 211.00
AAIF Live PriceLast checked at -
abrdn Asian Income is an Investment Trust

To provide investors with a total return primarily through investing in Asia Pacific securities, including those with an above average yield. The Company aims to grow its dividends over time.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Mgmt. Fee & Reinvestment of Fees by Manager

4 Mar 2024 11:24

RNS Number : 4787F
abrdn Asian Income Fund Limited
04 March 2024
 

abrdn Asian Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300U76MLZF5F8MN87

 

4 March 2024

 

New Management Fee and Reinvestment of Fees by the Manager

 

The Company's Board of Directors is delighted to announce a successful negotiation resulting in a reduction of the management fee the Company pays to abrdn, effective from the beginning of the current financial year starting January 1, 2024. The new fee structure will be determined by the lower of the Company's market capitalisation or net asset value, a change aimed at better aligning the fee with shareholders' interests. The fee will be calculated monthly at a rate of 0.75% per annum on market capitalisation (or net assets, whichever is lower) up to £300 million, and 0.60% for amounts exceeding this threshold. This adjustment is anticipated to decrease the Company's overall ongoing charges for the financial year ending December 31, 2024, by approximately 17% compared to the previous year. Detailed information regarding the Company's ongoing charges for the year ending December 31, 2023, will be provided with the announcement of the Company's financial results expected by the end of March.Furthermore, we are pleased to announce that abrdn has initiated its reinvestment of management fees program by subscribing to 190,000 shares of the Company as of today's date, equivalent to approximately three months' worth of management fees.Ian Cadby, Chairman, commented:"Amid these challenging times for the investment company industry, we find it gratifying to report a meaningful reduction in overall costs for our shareholders in the upcoming year. We also commend our manager for demonstrating its support for the Company through the reinvestment of management fees program, reaffirming its commitment to reinvest a portion of the fees back into the Company."

 

 

abrdn Investments Limited

Administrator

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFLVSISIIS
Date   Source Headline
15th Nov 202311:58 amRNSNet Asset Value(s)
14th Nov 20235:21 pmRNSTransaction in Own Shares
14th Nov 202312:52 pmRNSNet Asset Value(s)
14th Nov 202312:25 pmRNSPortfolio disclosure
13th Nov 20235:25 pmRNSTransaction in Own Shares
13th Nov 20234:41 pmRNSGearing disclosure
13th Nov 202312:49 pmRNSNet Asset Value(s)
10th Nov 20235:08 pmRNSTransaction in Own Shares
10th Nov 202312:32 pmRNSNet Asset Value(s)
9th Nov 20235:16 pmRNSTransaction in Own Shares
9th Nov 202312:21 pmRNSNet Asset Value(s)
8th Nov 202311:22 amRNSNet Asset Value(s)
7th Nov 20235:16 pmRNSTransaction in Own Shares
7th Nov 202312:35 pmRNSNet Asset Value(s)
6th Nov 20235:21 pmRNSMonth End Net Asset Value(s)
6th Nov 20232:42 pmRNSGearing disclosure
6th Nov 20231:26 pmRNSNet Asset Value(s)
6th Nov 202312:05 pmRNSDirector/PDMR Shareholding
3rd Nov 20235:16 pmRNSTransaction in Own Shares
3rd Nov 202312:45 pmRNSNet Asset Value(s)
3rd Nov 202312:20 pmRNSDirector/PDMR Shareholding
2nd Nov 20235:06 pmRNSTransaction in Own Shares
2nd Nov 202312:03 pmRNSNet Asset Value(s)
1st Nov 20235:09 pmRNSTransaction in Own Shares
1st Nov 202310:12 amRNSTotal Voting Rights
31st Oct 20235:14 pmRNSTransaction in Own Shares
31st Oct 20231:00 pmRNSNet Asset Value(s)
30th Oct 20235:49 pmRNSTransaction in Own Shares
30th Oct 20232:53 pmRNSGearing disclosure
30th Oct 202312:03 pmRNSNet Asset Value(s)
27th Oct 202312:26 pmRNSNet Asset Value(s)
26th Oct 20231:09 pmRNSNet Asset Value(s)
25th Oct 202312:45 pmRNSNet Asset Value(s)
24th Oct 202312:32 pmRNSNet Asset Value(s)
23rd Oct 202312:48 pmRNSGearing disclosure
23rd Oct 202311:35 amRNSNet Asset Value(s)
20th Oct 202312:08 pmRNSNet Asset Value(s)
19th Oct 202312:12 pmRNSNet Asset Value(s)
18th Oct 202312:15 pmRNSNet Asset Value(s)
17th Oct 202311:20 amRNSNet Asset Value(s)
16th Oct 20232:52 pmRNSGearing disclosure
16th Oct 20231:31 pmRNSNet Asset Value(s)
13th Oct 20235:32 pmRNSPortfolio disclosure
13th Oct 202312:01 pmRNSNet Asset Value(s)
12th Oct 20235:15 pmRNSTransaction in Own Shares
12th Oct 202311:51 amRNSNet Asset Value(s)
11th Oct 202311:43 amRNSNet Asset Value(s)
10th Oct 20235:33 pmRNSTransaction in Own Shares
10th Oct 20232:25 pmRNSThird Interim Dividend
10th Oct 202312:48 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.